
Cohere
enterprise foundation-model platform · private B2B LLM + agent software (sovereign + multilingual)
Series A (Sep-2021, $40M) and Series B (Feb-2022, $125M) valuations were never disclosed, so omitted. Apr-2026 ~$20B is a term-sheet/Series E figure tied to the Aleph Alpha merger and had not closed as of June 2026. Oct-2026: the Series E's initial close (company C$35.7B; Bloomberg $20.5B pre-money plus a round of up to $5B, ~US$25.5B post if fully raised) is the first priced point above the Apr-2026 term sheet; the Aleph Alpha combination is still awaiting approval.
Sources — 6 figures with citations
- Series E initial closefiled2026-10-29Initial close announced Oct 29 2026; the round targets C$7 billion at a C$35.7 billion valuation (company); Bloomberg: up to $5 billion at a $20.5 billion pre-money; led by Schwarz Group, with the Government of Canada (up to $1.14 billion per Bloomberg), Nvidia, Bell Ventures and Bullhound Capital; the amount closed was not disclosedlightreading.com — Company release via Light Reading; Bloomberg via The Next Web (REPORTED for the Bloomberg figures).
- ARR growthfiled2026-09-30165% year-over-year ARR growth through Q3 2026; customers up from 20 to 300 (company); 2025 ARR $240 million per the investor memo CNBC reported in February 2026thenextweb.com — Company statements at the Series E close; the absolute 2026 figure was not disclosed.
- Aleph Alpha combinationfiled2026-09-16Definitive business combination agreement signed Sep 16 2026, subject to final regulatory approvals; dual-headquartered in Berlin and Toronto; the founders said on Oct 29 the deal will complete within the next 12 monthssiliconangle.com — SiliconANGLE on the Sep 16 agreement; The Next Web (Oct 29 2026) on the revised timing (REPORTED).
- Gross margin and deployment mixfiled2026-09-12Gross margin around 70%; about 85% of revenue from private deploymentsforkast.news — Forkast, Sep 12 2026 (REPORTED).
- Watched signal: Series E / Aleph Alpha regulatory close — resolvedfiled2026-10-29Series E initially closed Oct 29 2026 at C$35.7B (~US$25.5B); the Aleph Alpha combination remains subject to approval, now expected within 12 months (founders, Oct 29 2026)thenextweb.com — Outcome of a signal this entry said to watch; recorded Nov 13 2026 (REPORTED for the timing).
- Watched signal: ARR print vs the >50% QoQ trajectory — resolvedfiled2026-09-30165% year-over-year ARR growth through Q3 2026 (company) — below the >50% quarter-on-quarter pace the item assumed; the deceleration trigger firedlightreading.com — Outcome of a signal this entry said to watch; recorded Nov 13 2026.
The thesis on this name
State of Frontier AI
Enterprise/sovereign-AI specialist with a real niche: ~85% of revenue from private/on-prem deployments (Oracle, RBC, LG, Fujitsu, Notion), ~$240M ARR in 2025 (beat its $200M target) and ARR growing 165% year over year through Q3 2026 (company); the Series E's initial close on Oct 29 2026 values it at C$35.7B (company; Bloomberg: $20.5B pre-money, up to $5B), so the price-to-ARR discount of the $7B era is gone — the 'undervalued' leg of this bucket closed with the Series E; what remains is the sovereign/private-deployment niche at a full price, so conviction moves to low. The June watch item on >50% quarter-on-quarter growth has resolved against the case (a deceleration). The thesis is the regulated-industry / data-residency moat that hyperscaler-hosted models can't fully address. High-potential only IF that niche scales; the risk is being out-grown in the same accounts.
Earnings, margins, COGS & capex
No public 10-K/10-Q exists. Best available: a Feb-2026 investor memo (via CNBC) putting 2025 ARR at ~$240M, >50% QoQ growth, ~70% gross margin, profitability targeted 2029. Total equity raised ~$1.54B over 7 rounds pre-Series-E (Tracxn). Revenue is concentrated in regulated verticals (financial services, healthcare, telecom, public sector, manufacturing). Unit economics lean on (a) selling models that deploy inside the customer's VPC / on-prem ('Model Vault') rather than only metered API, and (b) inference efficiency vs. frontier-scale labs. The single largest gap vs. a public peer: no disclosed burn or path-to-profit detail beyond the 2029 target — treat the 2029 profitability claim as management guidance, unverifiable.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~30¢ is cost of goods and ~70¢ operating expense, leaving ~0¢ of operating profit.
Revenue trend
Margins
COGS structure
Not disclosed (private company).
Capex
Not disclosed.
Growth drivers
- Profitable-trajectory economics (70% GM, 2029 profitability target) differentiate it from cash-incinerating frontier labs — a 'pure-play AI investment' that can actually print money
- Sovereign/regulated demand is real and growing — Schwarz/German-government anchor, RBC, Thales, Saab, Hanwha Ocean, Ensemble Health — verticals where data control beats benchmark scores
- North + Model Vault move it from a model vendor to an enterprise agent-software platform, raising ASPs, retention, and the multiple
- Strategic backers (NVIDIA, AMD, Salesforce, Oracle, Cisco, Schwarz) are also distribution + compute partners, compounding GTM reach
Bull & bear
The capital-efficient enterprise pure-play: ~70% margins and >50% QoQ growth on a real ~$240M ARR base, a defensible sovereignty + multilingual wedge into the one buyer pool (regulated enterprise + government) the US hyperscalers structurally underserve, and a 2027 IPO that would make it the only listed pure-play enterprise-AI lab. Checked Nov 13 2026: ARR grew 165% year over year through Q3 2026 (company) — fast, but below the >50% quarter-on-quarter pace (~400% annualised) this case assumed — while the Series E's initial close on Oct 29 2026 repriced the company at C$35.7B (company; Bloomberg $20.5B pre-money, round of up to $5B — REPORTED) with the Government of Canada and Nvidia in.
- Profitable-trajectory economics (70% GM, 2029 profitability target) differentiate it from cash-incinerating frontier labs — a 'pure-play AI investment' that can actually print money
- Sovereign/regulated demand is real and growing: Schwarz/German-government anchor, RBC, Thales, Saab, Hanwha Ocean, Ensemble Health — verticals where data control beats benchmark scores
- North + Model Vault move it from a model vendor to an enterprise agent-software platform, raising ASPs, retention, and the multiple
- Strategic backers (NVIDIA, AMD, Salesforce, Oracle, Cisco, Schwarz) are also distribution + compute partners, compounding GTM reach
- Scarcity at IPO — public-market investors have almost no way to own a pure enterprise-AI model lab; Cohere could command a scarcity premium on a TSX/Nasdaq debut
A sub-scale model lab carrying an ~80x-ARR mark, squeezed between frontier labs with ~50x its capital above and commoditizing open-weights below, whose entire thesis rests on a sovereign-AI procurement channel that is still more promise than proven revenue. Checked Nov 13 2026: the deceleration trigger has fired — 165% a year against the >50% a quarter the June case assumed (company) — the Aleph Alpha combination (agreed Sep 16 2026) is still awaiting approval, with the founders now saying within 12 months, and the new mark — roughly US$25.5B at the Series E (Bloomberg pre-money plus the round, REPORTED; company C$35.7B) — is ~40–60x ARR depending on the base (165% applied to a ~$160M Q3 2025 base gives ~$0.42B, to the $240M year-end base ~$0.64B; derived) — rich either way, though no longer the ~80x of the June frame.
- ~US$25.5B on ~$0.4–0.6B of ARR (derived) is ~40–60x — pricing flawless execution; the growth rate has already stepped down from >50% a quarter to 165% a year, and an inference price war would re-rate it hard
- Command is not benchmark-leading; if enterprises decide 'frontier-or-open-weights' and skip the middle, Cohere's positioning erodes
- Hyperscalers (AWS/Azure/Google) are adding the exact sovereignty/residency features Cohere sells, natively bundled — the standalone moat may be temporary
- Sovereign-AI revenue is concentrated, politically driven, and lumpy; the German-anchor thesis is unproven at scale and the Aleph Alpha combination has not closed
- Merger integration + dual-HQ + regulatory approval add execution risk right as it tries to IPO — a stumble strands the mark and the window
What it is worth
Private-company triangulation: last priced round vs ARR multiple, sanity-checked by what the mark implies. The Series E initially closed Oct 29 2026 at C$35.7B (company; Bloomberg: $20.5B pre-money and a round of up to $5B — roughly US$25.5B post if fully raised, REPORTED), replacing the Sep 2025 $7B Series D mark and the ~$20B Series E term sheet of April 2026. ARR: $240M exiting 2025 (investor memo via CNBC), up 165% year over year through Q3 2026 (company; absolute figure not disclosed), which puts Q3 2026 ARR at roughly $0.4–0.6B depending on the base (derived) and the mark at ~40–60x ARR. Reverse read: ~US$25B requires multi-billion ARR within ~4–5 years at a growth rate that has already stepped down from >50% a quarter to ~165% a year, AND ~70% gross margins (press, REPORTED) through an inference price war — aggressive for the category leader in sovereign enterprise AI.
~$10–15B
a down round from the Series E if growth decelerates further, an inference price war compresses margins, the Aleph Alpha combination fails its approvals, or a soft AI-IPO market re-rates the mark toward the private-deployment comps.
~$20–25B
the Series E mark holds into a 2027 listing; growth moderates toward ~100% a year, margins hold ~70% (REPORTED), the sovereign thesis is partly proven; the multiple compresses toward ~25–30x ARR as ARR scales.
~$35–45B at or after a 2027 listing — if ARR keeps compounding above 100% a year toward ~$1–1.5B by 2027, the Aleph Alpha combination closes and the sovereign channel (Canada, Germany) converts to scaled recurring revenue, with public markets paying a scarcity premium for the only pure-play enterprise-AI lab.
SWOT
Strengths
- ~70% gross margins and ~$240M ARR exiting 2025, grown at >50% a quarter through 2025 and 165% year over year through Q3 2026 (company) — capital-efficient relative to frontier labs that burn far more per dollar of revenue
- Enterprise-only focus — no consumer product to subsidize, no B2C distraction; sells security, data residency, multilingual depth, and in-VPC deployment
- Multilingual moat — Command/Embed and the Aya/Tiny-Aya family cover 70-100+ languages incl. low-resource Indic/African dialects, a genuine differentiator for sovereign + non-US buyers
- Blue-chip strategic cap table — NVIDIA, AMD, Salesforce, Cisco, Oracle, Fujitsu, PSP, plus (pending) Schwarz Group as anchor European customer/investor
- North agent platform (GA Aug 2025) moves Cohere up-stack from raw models to an enterprise agent + RAG workspace, raising switching costs
Weaknesses
- Capital disadvantage — competes against OpenAI/Anthropic/Google with arguably ~50x the capital; can be out-spent on frontier training and on inference price wars
- Model-quality perception gap — Command is not viewed as a frontier-leading model on public benchmarks vs. GPT/Claude/Gemini; sells on fit + security, not raw capability
- ARR base (~$240M exiting 2025, growing 165% year over year through Q3 2026) is an order of magnitude below OpenAI/Anthropic, so the ~US$25.5B Series E mark is a rich ~40–60x ARR (derived) — execution-dependent
- Heavy reliance on partner GTM (Oracle, Dell, SAP, Fujitsu, LG CNS, RBC) and on the as-yet-unproven sovereign-AI government-procurement channel
- Merger-integration + dual-HQ (Toronto/Berlin) complexity — the Aleph Alpha combination signed Sep 16 2026 is still awaiting regulatory approval (founders: within 12 months), and the Series E has only initially closed
Opportunities
- Sovereign AI — governments (Germany via Schwarz/anchor, Canada, EU public sector) buying non-US, data-resident models is a structurally growing, hyperscaler-underserved pool
- 2027 IPO as the *only listed pure-play enterprise-AI model lab* — scarcity value for public investors wanting AI exposure without consumer-platform risk
- Agentic enterprise workflows (North) — moving from per-token API to seat/workflow-priced software expands TAM and margin
- Aleph Alpha merger unlocks EU public-sector relationships, regulatory credibility, and German-government anchor demand
- Regulated verticals (banking, healthcare, defense — e.g. Saab, Thales, Hanwha Ocean, RBC) where data-control requirements favor Cohere's deployment model over multi-tenant APIs
Threats
- Inference price war — hyperscalers subsidizing model costs could compress Cohere's premium and its ~70% margin
- Open-weight models (Llama, Mistral, Qwen, DeepSeek) commoditizing the 'good-enough enterprise model' tier Cohere targets
- Hyperscaler bundling — AWS Bedrock, Azure OpenAI, Google Vertex offer enterprise security + sovereignty features natively, undercutting the standalone pitch
- Frontier-capability gap widening faster than Cohere's efficiency edge can compensate
- IPO-window / macro risk — a soft 2027 AI-IPO market or an AI-capex pullback could strand the rich Series E mark
Moats, dependencies & bottlenecks
Moats
70-100+ languages) — hard for US-centric labs to match and central to the sovereign pitch
data never leaves the customer's network, the structural answer to regulated buyers who can't use multi-tenant APIs
Sovereign-AI + government credibility (amplified by Aleph Alpha's EU public-sector relationships and Schwarz/German-government anchor)
Enterprise switching costs via North agent platform + Embed/Rerank RAG stack embedded in customer workflows
AMD, Salesforce/Oracle/SAP/Dell/Fujitsu/Cisco distribution) that doubles as GTM
Dependencies
supply, pricing, and allocation
Dell, AWS/Azure/Google marketplaces) for hosting + enterprise reach
Fujitsu, LG CNS, Salesforce) — limited direct sales scale vs. hyperscalers
now expected within 12 months of Oct 29 2026) and the Series E's final close (initial close Oct 29 2026), to realize the EU anchor-customer + sovereign thesis
a regulated-buyer procurement channel that is still maturing
Advantages
- Best-positioned independent for the regulated/sovereign enterprise + government segment specifically
- Capital efficiency (~70% GM, profitability targeted) vs. cash-burning peers — a cleaner equity story for public markets
- Pure-play enterprise focus — no consumer-platform safety/PR/regulatory baggage
- Canada/EU domicile + multilingual depth = a credible non-US alternative for buyers wary of US data jurisdiction
- Transatlantic footprint (Toronto + Germany) post-merger, with Western-government goodwill
Weaknesses
- Sub-frontier model perception limits its ceiling in capability-led deals
- An order-of-magnitude smaller ARR base than the leading labs, against a rich mark
- Concentration risk in a few large strategic partners and anchor government customers
- Margin exposure to an industry-wide inference price war
- No public financials / no S-1 yet — investors are underwriting a reported memo, not audited disclosure
Bottlenecks
- Capital intensity of staying near the model-quality frontier with ~50x less funding than OpenAI/Anthropic/Google
- Talent + compute access in a market where the hyperscalers monopolize both
- Length and lumpiness of government / regulated-enterprise sales cycles
- Proving the sovereign-AI revenue thesis converts from announcements (Schwarz, Saab, Hanwha) into recurring scaled ARR
- Closing the Aleph Alpha combination (approvals pending) and the Series E's remaining tranche, and integrating Aleph Alpha without disrupting the listing timeline
Top signals & trends
Top signals
The analysis text is as of the entry's stated date and predates these events unless dated otherwise.
Closing crystallizes the ~$20B mark, the Schwarz anchor, and the EU sovereign channel; a delay or down-round re-rates the equity. Resolved Nov 13 2026: the Series E initially closed Oct 29 2026 at C$35.7B (~US$25.5B); the Aleph Alpha combination's definitive agreement was signed Sep 16 2026 and remains subject to regulatory approval, with the founders now saying within 12 months.
Sustained >50% QoQ (~$360-400M ARR by mid-2026) validates the multiple; any deceleration is the bear trigger. Resolved Nov 13 2026: the company reported 165% year-over-year ARR growth through Q3 2026 — below the >50% quarter-on-quarter pace (~400% annualised) this item assumed; the deceleration trigger has fired.
First audited financials + burn disclosure — the moment the reported memo becomes verifiable. Watched for 2027.
Turns the sovereign-AI thesis from press releases into scaled recurring revenue.
Watch whether the capability gap widens; a widening gap undercuts non-security deals.
Trends
Structurally growing, hyperscaler-underserved pool that is Cohere's core wedge; amplified by EU/Canada policy.
Higher ASPs, stickier seats, better multiple — Cohere is moving up-stack into it.
Hyperscaler subsidies could compress the premium and the ~70% margin.
Llama/Mistral/Qwen/DeepSeek pressure the exact mid-tier Cohere targets; pushes it to compete on deployment + security, not the model.
Native sovereignty + security features in the big clouds erode the standalone pitch.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
GPUs for training/inference + strategic investor.
Instinct accelerators + strategic investor (AMD Ventures).
OCI compute + partner; hosting and enterprise distribution.
Financial-services flagship customer (North / Command).
Customer + partner for on-prem enterprise AI deployment.
Partner embedding Cohere models into enterprise software workflows.
Partner + customer; Japan/APAC enterprise + public-sector distribution.
Defense/aerospace partnership — sovereign-AI vertical proof point (2026).
GPT via Azure OpenAI — the enterprise default; bundles sovereignty/residency natively, the biggest standalone-pitch threat.
Claude — the other enterprise-trusted frontier lab; far larger ARR + capital, strong in regulated verticals via AWS/GCP.
Gemini + Vertex AI; sovereign-cloud offerings and frontier models compete directly for regulated/government buyers.
Bedrock multi-model marketplace + Nova models; the distribution layer Cohere must ride and fight simultaneously.
The European sovereign-AI rival with open-weight + government positioning — the most direct head-to-head on Cohere's EU/sovereign thesis.
Enterprise data-platform players embedding models + governance where the data already lives — adjacent competition for the enterprise-AI budget.